{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:32:56Z","timestamp":1785889976619,"version":"3.56.0"},"reference-count":40,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.3934\/microbiol.2021003","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T02:57:50Z","timestamp":1611111470000},"page":"28-39","source":"Crossref","is-referenced-by-count":7,"title":["&lt;i&gt;In vitro&lt;\/i&gt; antifungal activity of pelgipeptins against human pathogenic fungi and &lt;i&gt;Candida albicans&lt;\/i&gt; biofilms"],"prefix":"10.3934","volume":"7","author":[{"given":"D\u00e9bora Lu\u00edza Albano","family":"Fulg\u00eancio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Graduate Program in Genomic Sciences and Biotechnology, Catholic University of Bras\u00edlia, Bras\u00edlia, Brazil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosiane Andrade","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Guilhelmelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calliandra Maria de Souza","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Barros","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Fellipe","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Spezia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildinete","family":"Silva-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine Chaves","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Laboratory of Molecular Biology, Department of Cellular Biology, Institute of Biological Sciences, University of Bras\u00edlia, Bras\u00edlia, Brazil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Ceilandia, University of Bras\u00edlia, Bras\u00edlia, Brazil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2321","reference":[{"key":"key-10.3934\/microbiol.2021003-1","unstructured":"Calderone RA, Fonzi WA (2001) Virulence factors of <i>Candida albicans<\/i>.&nbsp;<i>Trends Microbiol<\/i>&nbsp;9: 327-335."},{"key":"key-10.3934\/microbiol.2021003-2","doi-asserted-by":"crossref","unstructured":"Shikanai-Yasuda MA (2015) Paracoccidioidomycosis treatment.&nbsp;<i>Rev Inst Med Trop Sao Paulo<\/i>&nbsp;57: 31-37.","DOI":"10.1590\/S0036-46652015000700007"},{"key":"key-10.3934\/microbiol.2021003-3","doi-asserted-by":"crossref","unstructured":"Bongomin F, Gago S, Oladele RO, et al. (2017) Global and multi-national prevalence of fungal diseases\u2014estimate precision.&nbsp;<i>J Fungi<\/i>&nbsp;3: 57.","DOI":"10.3390\/jof3040057"},{"key":"key-10.3934\/microbiol.2021003-4","doi-asserted-by":"crossref","unstructured":"Sudbery PE (2011) Growth of <i>Candida albicans<\/i> hyphae.&nbsp;<i>Nat Rev Microbiol<\/i>&nbsp;9: 737-748.","DOI":"10.1038\/nrmicro2636"},{"key":"key-10.3934\/microbiol.2021003-5","doi-asserted-by":"crossref","unstructured":"Horn DL, Neofytos D, Anaissie EJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.&nbsp;<i>Clin Infect Dis<\/i>&nbsp;48: 1695-1703.","DOI":"10.1086\/599039"},{"key":"key-10.3934\/microbiol.2021003-6","doi-asserted-by":"crossref","unstructured":"Ramage G, Mowat E, Jones B, et al. (2009) Our current understanding of fungal biofilms.&nbsp;<i>Crit Rev Microbiol<\/i>&nbsp;35: 340-355.","DOI":"10.3109\/10408410903241436"},{"key":"key-10.3934\/microbiol.2021003-7","doi-asserted-by":"crossref","unstructured":"Levitz SM (1991) The ecology of <i>Cryptococcus neoformans<\/i> and the epidemiology of cryptococcosis.&nbsp;<i>Rev Infect Dis<\/i>&nbsp;13: 1163-1169.","DOI":"10.1093\/clinids\/13.6.1163"},{"key":"key-10.3934\/microbiol.2021003-8","doi-asserted-by":"crossref","unstructured":"Idnurm A, Bahn YS, Nielsen K, et al. (2005) Deciphering the model pathogenic fungus <i>Cryptococcus neoformans<\/i>.&nbsp;<i>Nat Rev Microbiol<\/i>&nbsp;3: 753-764.","DOI":"10.1038\/nrmicro1245"},{"key":"key-10.3934\/microbiol.2021003-9","doi-asserted-by":"crossref","unstructured":"Velagapudi R, Hsueh YP, Geunes-Boyer S, et al. (2009) Spores as infectious propagules of <i>Cryptococcus neoformans<\/i>.&nbsp;<i>Infect Immun<\/i>&nbsp;77: 4345-4355.","DOI":"10.1128\/IAI.00542-09"},{"key":"key-10.3934\/microbiol.2021003-10","doi-asserted-by":"crossref","unstructured":"Rajasingham R, Smith RM, Park BJ, et al. (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.&nbsp;<i>Lancet Infect Dis<\/i>&nbsp;17: 873-881.","DOI":"10.1016\/S1473-3099(17)30243-8"},{"key":"key-10.3934\/microbiol.2021003-11","unstructured":"San-Blas F, Cova LJ (1975) Growth curves of the yeast-like form of <i>Paracocidioides brasiliensis<\/i>.&nbsp;<i>Sabouraudia<\/i>&nbsp;1: 22-29."},{"key":"key-10.3934\/microbiol.2021003-12","doi-asserted-by":"crossref","unstructured":"San-Blas G (1985) <i>Paracoccidioides brasiliensis<\/i>: Cell Wall Glucans, Pathogenicity, and Dimorphism.&nbsp;<i>Current Topics in Medical Mycology<\/i>&nbsp;New York: Springer, 235-257.","DOI":"10.1007\/978-1-4613-9547-8_9"},{"key":"key-10.3934\/microbiol.2021003-13","doi-asserted-by":"crossref","unstructured":"Mendes RP, Cavalcante R de S, Marques SA, et al. (2017) Paracoccidioidomycosis: Current perspectives from Brazil.&nbsp;<i>Open Microbiol J<\/i>&nbsp;11: 224-282.","DOI":"10.2174\/1874285801711010224"},{"key":"key-10.3934\/microbiol.2021003-14","unstructured":"da Costa MM, Marques da Silva SH (2014) Epidemiology, clinical, and therapeutic aspects of Paracoccidioidomycosis.&nbsp;<i>Curr Trop Med Reports<\/i>&nbsp;1: 138-144."},{"key":"key-10.3934\/microbiol.2021003-15","doi-asserted-by":"crossref","unstructured":"Stein T (2005) <i>Bacillus subtilis<\/i> antibiotics: structures, syntheses and specific functions.&nbsp;<i>Mol Microbiol<\/i>&nbsp;56: 845-857.","DOI":"10.1111\/j.1365-2958.2005.04587.x"},{"key":"key-10.3934\/microbiol.2021003-16","unstructured":"Cochrane SA, Vederas JC (2016) Lipopeptides from <i>Bacillus<\/i> and <i>Paenibacillus<\/i> spp.: a gold mine of antibiotic candidates.&nbsp;<i>Med Res Rev<\/i>&nbsp;36: 4-31."},{"key":"key-10.3934\/microbiol.2021003-17","unstructured":"Meena KR, Kanwar SS (2015) Lipopeptides as the antifungal and antibacterial agents: applications in food safety and therapeutics.&nbsp;<i>Biomed Res Int<\/i>&nbsp;2015: 473050."},{"key":"key-10.3934\/microbiol.2021003-18","doi-asserted-by":"crossref","unstructured":"Olishevska S, Nickzad A, D\u00e9ziel E (2019) <i>Bacillus<\/i> and <i>Paenibacillus<\/i> secreted polyketides and peptides involved in controlling human and plant pathogens.&nbsp;<i>Appl Microbiol Biotechnol<\/i>&nbsp;103: 1189-1215.","DOI":"10.1007\/s00253-018-9541-0"},{"key":"key-10.3934\/microbiol.2021003-19","doi-asserted-by":"crossref","unstructured":"Velkov T, Roberts KD, Nation RL, et al. (2013) Pharmacology of polymyxins: new insights into an \u2018old\u2019 class of antibiotics.&nbsp;<i>Future Microbiol<\/i>&nbsp;8: 711-724.","DOI":"10.2217\/fmb.13.39"},{"key":"key-10.3934\/microbiol.2021003-20","unstructured":"Wu XC, Shen XB, Ding R, et al. (2010) Isolation and partial characterization of antibiotics produced by <i>Paenibacillus elgii<\/i> B69.&nbsp;<i>FEMS Microbiol Lett<\/i>&nbsp;310: 32-38."},{"key":"key-10.3934\/microbiol.2021003-21","doi-asserted-by":"crossref","unstructured":"Ding R, Wu XC, Qian CD, et al. (2011) Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant <i>Staphylococcus aureus<\/i>.&nbsp;<i>J Microbiol<\/i>&nbsp;49: 942-949.","DOI":"10.1007\/s12275-011-1153-7"},{"key":"key-10.3934\/microbiol.2021003-22","doi-asserted-by":"crossref","unstructured":"Costa R, Ortega D, Fulg\u00eancio D, et al. (2019) Checkerboard testing method indicates synergic effect of pelgipeptins against multidrug resistant <i>Klebsiella pneumoniae<\/i>.&nbsp;<i>Biotechnol Res Innov<\/i>&nbsp;3: 187-191.","DOI":"10.1016\/j.biori.2018.12.001"},{"key":"key-10.3934\/microbiol.2021003-23","doi-asserted-by":"crossref","unstructured":"Ortega DB, Costa RA, Pires AS, et al. (2018) Draft Genome sequence of the antimicrobial-producing strain <i>Paenibacillus elgii<\/i> AC13.&nbsp;<i>Genome Announc<\/i>&nbsp;6: e00573-18.","DOI":"10.1128\/genomeA.00573-18"},{"key":"key-10.3934\/microbiol.2021003-24","unstructured":"Murphy JB, Kies MW (1960) Note on spectrophotometric determination of proteins in dilute solutions.&nbsp;<i>Biochim Biophys Acta<\/i>&nbsp;45: 382-384."},{"key":"key-10.3934\/microbiol.2021003-25"},{"key":"key-10.3934\/microbiol.2021003-26","doi-asserted-by":"crossref","unstructured":"De-Souza-Silva CM, Guilhelmelli F, Zamith-Miranda D, et al. (2018) Broth microdilution in vitro screening: An easy and fast method to detect new antifungal compounds.&nbsp;<i>J Vis Exp<\/i>&nbsp;132: 57127.","DOI":"10.3791\/57127"},{"key":"key-10.3934\/microbiol.2021003-27","doi-asserted-by":"crossref","unstructured":"Pankey G, Ashcraft D, Kahn H, et al. (2014) Time-kill assay and etest evaluation for synergy with polymyxin B and fluconazole against <i>Candida glabrata<\/i>.&nbsp;<i>Antimicrob Agents Chemother<\/i>&nbsp;58: 5795-5800.","DOI":"10.1128\/AAC.03035-14"},{"key":"key-10.3934\/microbiol.2021003-28","doi-asserted-by":"crossref","unstructured":"Hsu LH, Wang HF, Sun PL, et al. (2017) The antibiotic polymyxin B exhibits novel antifungal activity against <i>Fusarium<\/i> species.&nbsp;<i>Int J Antimicrob Agents<\/i>&nbsp;49: 740-748.","DOI":"10.1016\/j.ijantimicag.2017.01.029"},{"key":"key-10.3934\/microbiol.2021003-29","doi-asserted-by":"crossref","unstructured":"De Paula E Silva ACA, Oliveira HC, Silva JF, et al. (2013) Microplate alamarblue assay for paracoccidioides susceptibility testing.&nbsp;<i>J Clin Microbiol<\/i>&nbsp;51: 1250-1252.","DOI":"10.1128\/JCM.02914-12"},{"key":"key-10.3934\/microbiol.2021003-30","doi-asserted-by":"crossref","unstructured":"Pierce CG, Uppuluri P, Tristan AR, et al. (2008) A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.&nbsp;<i>Nat Protoc<\/i>&nbsp;3: 1494-1500.","DOI":"10.1038\/nprot.2008.141"},{"key":"key-10.3934\/microbiol.2021003-31","doi-asserted-by":"crossref","unstructured":"Pirri G, Giuliani A, Nicoletto SF, et al. (2009) Lipopeptides as anti-infectives: a practical perspective.&nbsp;<i>Cent Eur J Biol<\/i>&nbsp;4: 258-273.","DOI":"10.2478\/s11535-009-0031-3"},{"key":"key-10.3934\/microbiol.2021003-32","doi-asserted-by":"crossref","unstructured":"Trimble MJ, Mlyn\u00e1r\u010dik P, Kol\u00e1\u0159 M, et al. (2016) Polymyxin: Alternative mechanisms of action and resistance.&nbsp;<i>Cold Spring Harb Perspect Med<\/i>&nbsp;6: 1-23.","DOI":"10.1101\/cshperspect.a025288"},{"key":"key-10.3934\/microbiol.2021003-33","doi-asserted-by":"crossref","unstructured":"Zhai B, Zhou H, Yang L, et al. (2010) Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.&nbsp;<i>J Antimicrob Chemother<\/i>&nbsp;65: 931-938.","DOI":"10.1093\/jac\/dkq046"},{"key":"key-10.3934\/microbiol.2021003-34","doi-asserted-by":"crossref","unstructured":"Qian CD, Liu TZ, Zhou SL, et al. (2012) Identification and functional analysis of gene cluster involvement in biosynthesis of the cyclic lipopeptide antibiotic pelgipeptin produced by <i>Paenibacillus elgii<\/i>.&nbsp;<i>BMC Microbiol<\/i>&nbsp;12: 197.","DOI":"10.1186\/1471-2180-12-197"},{"key":"key-10.3934\/microbiol.2021003-35","doi-asserted-by":"crossref","unstructured":"Campoy S, Adrio JL (2017) Antifungals.&nbsp;<i>Biochem Pharmacol<\/i>&nbsp;133: 86-96.","DOI":"10.1016\/j.bcp.2016.11.019"},{"key":"key-10.3934\/microbiol.2021003-36","doi-asserted-by":"crossref","unstructured":"Kim J, Il Kim P, Bong KM, et al. (2018) Isolation and structural elucidation of pelgipeptin E, a novel pore-forming pelgipeptin analog from <i>Paenibacillus elgii<\/i> with low hemolytic activity.&nbsp;<i>J Antibiot (Tokyo)<\/i>&nbsp;71: 1008-1017.","DOI":"10.1038\/s41429-018-0095-2"},{"key":"key-10.3934\/microbiol.2021003-37","doi-asserted-by":"crossref","unstructured":"Bachmann SP, VandeWalle K, Ramage G, et al. (2002) In vitro activity of caspofungin against <i>Candida albicans<\/i> biofilms.&nbsp;<i>Antimicrob Agents Chemother<\/i>&nbsp;46: 3591-3596.","DOI":"10.1128\/AAC.46.11.3591-3596.2002"},{"key":"key-10.3934\/microbiol.2021003-38","doi-asserted-by":"crossref","unstructured":"Bruzual I, Riggle P, Hadley S, et al. (2007) Biofilm formation by fluconazole-resistant <i>Candida albicans<\/i> strains is inhibited by fluconazole.&nbsp;<i>J Antimicrob Chemother<\/i>&nbsp;59: 441-450.","DOI":"10.1093\/jac\/dkl521"},{"key":"key-10.3934\/microbiol.2021003-39","doi-asserted-by":"crossref","unstructured":"Ramage G, Vande Walle K, Wickes BL, et al. (2001) Standardized method for in vitro antifungal susceptibility testing of <i>Candida albicans<\/i> biofilms.&nbsp;<i>Antimicrob Agents Chemother<\/i>&nbsp;45: 2475-2479.","DOI":"10.1128\/AAC.45.9.2475-2479.2001"},{"key":"key-10.3934\/microbiol.2021003-40","doi-asserted-by":"crossref","unstructured":"Ramage G, VandeWalle K, Lopez-Ribot J, et al. (2002) The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in <i>Candida albicans<\/i>.&nbsp;<i>FEMS Microbiol Lett<\/i>&nbsp;214: 95-100.","DOI":"10.1111\/j.1574-6968.2002.tb11330.x"}],"container-title":["AIMS Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/microbiol.2021003?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T02:57:57Z","timestamp":1611111477000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/microbiol.2021003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3934\/microbiol.2021003","relation":{},"ISSN":["2471-1888"],"issn-type":[{"value":"2471-1888","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}